Kim W, Lao Q, Shin Y-K, Carlson OD, Lee EK, Gorospe M, Kulkarni RN, Egan JM. Cannabinoids induce pancreatic beta-cell death by directly inhibiting insulin receptor activation. Sci. Signal. 2012;5(216):ra23–ra23.

Kebede M, Ferdaoussi M, Mancini A, Alquier T, Kulkarni RN, Walker MD, Poitout V. Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas-duodenum homeobox-1. Proceedings of the National Academy of Sciences. 2012;109(7):2376–2381.

Welters HJ, Ouaamari AE, Kawamori D, Meyer J, Hu J, Smith DM, Kulkarni RN. Rosiglitazone promotes PPAR$\gamma$-dependent and-independent alterations in gene expression in mouse islets. Endocrinology. 2012;153(10):4593–4599.

Kulkarni RN. Identifying biomarkers of subclinical diabetes. Diabetes. 2012;61(8):1925–1926.

Kulkarni RN, Mizrachi E-B, Ocana AG, Stewart AF. Human beta cell proliferation and intracellular signaling: driving in the dark without a roadmap. Diabetes. 2012;61(9):2205–2213.

Goldfine A, Kulkarni R. Insulin modulation of beta cell function: a translational journey from the bench to the bedside. Diabetes, Obesity and Metabolism. 2012;14:152–160.

Teo AKK, Kulkarni RN. Setting sail for glucose homeostasis with the AKAP150-PP2B-anchor. The EMBO journal. 2012;31(20):3956–3957.

Negahdar M, Aukrust I, Johansson BB, Molnes J, Molven A, Matschinsky FM, S\ovik O, Kulkarni RN, Flatmark T, Nj\olstad PR, et al. GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012;1822(11):1705–1715.

Zhou J-Y, Dann GP, Liew CW, Smith RD, Kulkarni RN, Qian W-J. Unraveling pancreatic islet biology by quantitative proteomics. Expert review of proteomics. 2011;8(4):495–504.

Kawamori D, Kulkarni RN. Molecular mechanism underlying the intra-islet regulation of glucagon secretion. Diabetes: Damages and Treatments. 2011:139.